Managing patients with primary pulmonary hypertension: prostacyclin therapy.
作者信息
Albert N M, Hague K
机构信息
Department of Advanced Clinical Practice Nursing, Cleveland Clinic Foundation, Ohio, USA.
出版信息
Am J Crit Care. 1997 Jul;6(4):274-80.
PMID:9215424
Abstract
摘要
相似文献
1
Managing patients with primary pulmonary hypertension: prostacyclin therapy.
Am J Crit Care. 1997 Jul;6(4):274-80.
2
Epoprostenol (prostacyclin) therapy in primary pulmonary hypertension.
N Engl J Med. 1998 Jun 11;338(24):1773-4. doi: 10.1056/NEJM199806113382414.
3
Epoprostenol therapy for primary pulmonary hypertension.
Crit Care Nurse. 1999 Aug;19(4):20-7.
4
Intravenous epoprostenol: a new therapy for primary pulmonary hypertension.
Crit Care Nurse. 2000 Dec;20(6):31-40.
5
Timeline of haemodynamic improvement with subcutaneous prostacyclin therapy in a patient with severe pulmonary arterial hypertension.
Eur J Clin Invest. 2008 Aug;38(8):603-4. doi: 10.1111/j.1365-2362.2008.01971.x.
6
Advances in prostacyclin therapy for pulmonary arterial hypertension.
Crit Care Nurse. 2004 Apr;24(2):42-8, 50-4.
7
[Therapy of severe pulmonary hypertension with prostacyclin and iloprost].
Dtsch Med Wochenschr. 2001 May 25;126(21):631-7. doi: 10.1055/s-2001-14422.
8
Prostacyclin therapy for pulmonary arterial hypertension: new directions.前列环素治疗肺动脉高压：新方向
Semin Respir Crit Care Med. 2005 Aug;26(4):394-401. doi: 10.1055/s-2005-916154.
9
Practical aspects of continuous intravenous treprostinil therapy.持续静脉输注曲前列尼尔治疗的实践要点
Crit Care Nurse. 2007 Apr;27(2):41-2, 44-5, 47-50; quiz 51.
10
Pharmacokinetic evaluation of continuous intravenous epoprostenol.连续静脉内依前列醇的药代动力学评价。
Expert Opin Drug Metab Toxicol. 2010 Dec;6(12):1587-98. doi: 10.1517/17425255.2010.534458.
Zotero 插件